266 related articles for article (PubMed ID: 37033916)
21. Lack of concordance between residual viremia and viral variants driving de novo infection of CD4(+) T cells on ART.
Puertas MC; Noguera-Julian M; Massanella M; Pou C; Buzon MJ; Clotet B; Stevenson M; Paredes R; Blanco J; Martinez-Picado J
Retrovirology; 2016 Aug; 13(1):51. PubMed ID: 27484989
[TBL] [Abstract][Full Text] [Related]
22. Sequence Evaluation and Comparative Analysis of Novel Assays for Intact Proviral HIV-1 DNA.
Gaebler C; Falcinelli SD; Stoffel E; Read J; Murtagh R; Oliveira TY; Ramos V; Lorenzi JCC; Kirchherr J; James KS; Allard B; Baker C; Kuruc JD; Caskey M; Archin NM; Siliciano RF; Margolis DM; Nussenzweig MC
J Virol; 2021 Feb; 95(6):. PubMed ID: 33361426
[TBL] [Abstract][Full Text] [Related]
23. Unequal distribution of genetically-intact HIV-1 proviruses in cells expressing the immune checkpoint markers PD-1 and/or CTLA-4.
Fisher K; Schlub TE; Boyer Z; Rasmussen TA; Rhodes A; Hoh R; Hecht FM; Deeks SG; Lewin SR; Palmer S
Front Immunol; 2023; 14():1064346. PubMed ID: 36776833
[TBL] [Abstract][Full Text] [Related]
24. Cell-based measures of viral persistence are associated with immune activation and programmed cell death protein 1 (PD-1)-expressing CD4+ T cells.
Hatano H; Jain V; Hunt PW; Lee TH; Sinclair E; Do TD; Hoh R; Martin JN; McCune JM; Hecht F; Busch MP; Deeks SG
J Infect Dis; 2013 Jul; 208(1):50-6. PubMed ID: 23089590
[TBL] [Abstract][Full Text] [Related]
25. Humanized Mouse Model of HIV-1 Latency with Enrichment of Latent Virus in PD-1
Llewellyn GN; Seclén E; Wietgrefe S; Liu S; Chateau M; Pei H; Perkey K; Marsden MD; Hinkley SJ; Paschon DE; Holmes MC; Zack JA; Louie SG; Haase AT; Cannon PM
J Virol; 2019 May; 93(10):. PubMed ID: 30842333
[TBL] [Abstract][Full Text] [Related]
26. Relationship between CCR5
Martínez-Bonet M; González-Serna A; Clemente MI; Morón-López S; Díaz L; Navarro M; Puertas MC; Leal M; Ruiz-Mateos E; Martinez-Picado J; Muñoz-Fernández MA
Clin Microbiol Infect; 2017 May; 23(5):318-324. PubMed ID: 28042001
[TBL] [Abstract][Full Text] [Related]
27. Heterogeneity of Latency Establishment in the Different Human CD4
Butta GM; Bozzi G; Gallo G; Copaloni G; Cordiglieri C; Crosti M; Mancino M; Prati D; Simon V; Gori A; Bandera A; De Francesco R; Manganaro L
J Virol; 2022 May; 96(10):e0037922. PubMed ID: 35499323
[TBL] [Abstract][Full Text] [Related]
28. A Novel Assay to Measure the Magnitude of the Inducible Viral Reservoir in HIV-infected Individuals.
Procopio FA; Fromentin R; Kulpa DA; Brehm JH; Bebin AG; Strain MC; Richman DD; O'Doherty U; Palmer S; Hecht FM; Hoh R; Barnard RJ; Miller MD; Hazuda DJ; Deeks SG; Sékaly RP; Chomont N
EBioMedicine; 2015 Aug; 2(8):874-83. PubMed ID: 26425694
[TBL] [Abstract][Full Text] [Related]
29. Initiation of Antiretroviral Therapy Restores CD4+ T Memory Stem Cell Homeostasis in Simian Immunodeficiency Virus-Infected Macaques.
Cartwright EK; Palesch D; Mavigner M; Paiardini M; Chahroudi A; Silvestri G
J Virol; 2016 Aug; 90(15):6699-6708. PubMed ID: 27170752
[TBL] [Abstract][Full Text] [Related]
30. A Novel Single-Cell FISH-Flow Assay Identifies Effector Memory CD4
Grau-Expósito J; Serra-Peinado C; Miguel L; Navarro J; Curran A; Burgos J; Ocaña I; Ribera E; Torrella A; Planas B; Badía R; Castellví J; Falcó V; Crespo M; Buzon MJ
mBio; 2017 Jul; 8(4):. PubMed ID: 28698276
[TBL] [Abstract][Full Text] [Related]
31. Expression of TIGIT, PD-1 and HLA-DR/CD38 markers on CD8-T cells of children and adolescents infected with HIV and uninfected controls.
Pereira-Manfro WF; Silva GPD; Costa PR; Costa DA; Ferreira BDS; Barreto DM; Frota ACC; Hofer CB; Kallas EG; Milagres LG
Rev Inst Med Trop Sao Paulo; 2023; 65():e14. PubMed ID: 36753067
[TBL] [Abstract][Full Text] [Related]
32. Low Peripheral T Follicular Helper Cells in Perinatally HIV-Infected Children Correlate With Advancing HIV Disease.
McCarty B; Mwamzuka M; Marshed F; Generoso M; Alvarez P; Ilmet T; Kravietz A; Ahmed A; Borkowsky W; Unutmaz D; Khaitan A
Front Immunol; 2018; 9():1901. PubMed ID: 30197641
[TBL] [Abstract][Full Text] [Related]
33. Red blood cell distribution width as an easily measurable biomarker of persistent inflammation and T cell dysregulation in antiretrovirally treated HIV-infected adults.
Zhang Z; Chew GM; Shikuma CM; Gangcuangco LMA; Souza SA; Shiramizu B; Nakamoto BK; Gong T; Mannem SR; Mitchell BI; Kallianpur KJ; Ndhlovu LC; Chow DC
HIV Clin Trials; 2018 Oct; 19(5):172-176. PubMed ID: 30422099
[TBL] [Abstract][Full Text] [Related]
34. T cell immune discriminants of HIV reservoir size in a pediatric cohort of perinatally infected individuals.
Rinaldi S; de Armas L; Dominguez-Rodríguez S; Pallikkuth S; Dinh V; Pan L; Gӓrtner K; Pahwa R; Cotugno N; Rojo P; Nastouli E; Klein N; Foster C; De Rossi A; Giaquinto C; Rossi P; Palma P; Pahwa S;
PLoS Pathog; 2021 Apr; 17(4):e1009533. PubMed ID: 33901266
[TBL] [Abstract][Full Text] [Related]
35. Soluble immune checkpoints as correlates for HIV persistence and T cell function in people with HIV on antiretroviral therapy.
Chiu CY; Schou MD; McMahon JH; Deeks SG; Fromentin R; Chomont N; Wykes MN; Rasmussen TA; Lewin SR
Front Immunol; 2023; 14():1123342. PubMed ID: 37056754
[TBL] [Abstract][Full Text] [Related]
36. Longitudinal clonal dynamics of HIV-1 latent reservoirs measured by combination quadruplex polymerase chain reaction and sequencing.
Cho A; Gaebler C; Olveira T; Ramos V; Saad M; Lorenzi JCC; Gazumyan A; Moir S; Caskey M; Chun TW; Nussenzweig MC
Proc Natl Acad Sci U S A; 2022 Jan; 119(4):. PubMed ID: 35042816
[TBL] [Abstract][Full Text] [Related]
37. Detection of Inducible Replication-Competent HIV-1 Subtype C Provirus Despite Long-Term Antiretroviral Treatment in Perinatally Infected Adolescents in Botswana.
Koofhethile CK; Moyo S; Kotokwe KP; Chang C; Mokgethi P; Muchoba L; Mokgweetsi S; Makhema J; Lockman S; Gaseitsiwe S; de Oliveira T; Essex M; Shapiro R; Kanki P; Novitsky V
AIDS Res Hum Retroviruses; 2021 Jan; 37(1):16-23. PubMed ID: 32935556
[TBL] [Abstract][Full Text] [Related]
38. VIP-SPOT: an Innovative Assay To Quantify the Productive HIV-1 Reservoir in the Monitoring of Cure Strategies.
Puertas MC; Bayón-Gil Á; Garcia-Guerrero MC; Salgado M; Urrea V; Morón-López S; Peña R; Jiménez-Moyano E; Clotet B; Prado JG; Martinez-Picado J
mBio; 2021 Jun; 12(3):e0056021. PubMed ID: 34154408
[TBL] [Abstract][Full Text] [Related]
39. HIV DNA subspecies persist in both activated and resting memory CD4+ T cells during antiretroviral therapy.
Murray JM; Zaunders JJ; McBride KL; Xu Y; Bailey M; Suzuki K; Cooper DA; Emery S; Kelleher AD; Koelsch KK;
J Virol; 2014 Mar; 88(6):3516-26. PubMed ID: 24403590
[TBL] [Abstract][Full Text] [Related]
40. Quantitation of replication-competent HIV-1 in populations of resting CD4+ T cells.
Soriano-Sarabia N; Bateson RE; Dahl NP; Crooks AM; Kuruc JD; Margolis DM; Archin NM
J Virol; 2014 Dec; 88(24):14070-7. PubMed ID: 25253353
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
